F.D.A. Approves New Anemia Drug
Tuesday, March 27, 2012 - 13:30
in Health & Medicine
A new anemia drug provides a less expensive alternative for dialysis patients and is likely to end Amgen’s 24-year monopoly.
A new anemia drug provides a less expensive alternative for dialysis patients and is likely to end Amgen’s 24-year monopoly.